Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced it was selected to be part of the Russell 2000®, Russell 3000® and Russell Global Indexes when the Russell Investment Group reconstitutes its family of U.S. indexes on June 26th, according to a preliminary list of additions posted Friday, June 19th on www.russell.com.

Membership in the Russell Indexes, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $4 trillion in assets currently are benchmarked to them.

Annual reconstitution of Russell indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000^® Index and Russell Microcap. The largest 1,000 companies in the ranking comprise the large-cap Russell 1000^® Index and the next 2,000 companies become the widely used small-cap Russell 2000^® Index. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.

This document may contain some forward looking statements, particularly regarding operational prospects in 2009 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings.

Investor Relations:
Buttonwood Advisory Group, Inc.
John Aneralla, 800-940-9087